Sort
64,565 grants matching “drug discovery”
UC BRAID Center for Accelerated Innovation
$2,155,154Michael J Palazzolo · University Of California Los Angeles · U54 · FY2014 · HL
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
$2,153,560Anita L Destefano · Boston University Medical Campus · U01 · FY2021 · AG
Cancer Risk in Human Populations
$2,153,446Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
SPORE in Breast Cancer
$2,153,378Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2021 · CA
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$2,152,710Bernard Mark Evers · University Of Kentucky · P30 · FY2022 · CA
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$2,152,710Bernard Mark Evers · University Of Kentucky · P30 · FY2021 · CA
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$2,152,710Bernard Mark Evers · University Of Kentucky · P30 · FY2019 · CA
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$2,152,710Bernard Mark Evers · University Of Kentucky · P30 · FY2020 · CA
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$2,152,710Bernard Mark Evers · University Of Kentucky · P30 · FY2018 · CA
Basic and Translational Studies of Inborn Errors of Metabolism
$2,152,087Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Brain-penetrant GPR88 agonists as novel therapeutics for opioid abuse
$2,150,978Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · DA
Case GI SPORE
$2,150,501Sanford D Markowitz · Case Western Reserve University · P50 · FY2013 · CA
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
$2,150,500Matthew D Ringel · Ohio State University · P50 · FY2013 · CA
The HMS Laboratory of Systems Pharmacology
$2,149,568Peter Karl Sorger · Harvard Medical School · P50 · FY2017 · GM
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$2,149,293Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2013 · AG
Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical program.
$2,149,117Hugh William Alsop · Kinoxis Therapeutics Pty Ltd · UH3 · FY2023 · DA
Injectable naltrexone 2-month depot formulations
$2,148,235Kinam Park · Purdue University · UG3 · FY2020 · DA
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
$2,147,504Anita L Destefano · Boston University Medical Campus · U01 · FY2022 · AG
Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral Sclerosis
$2,147,016Erez Eitan · Neurodex Inc · R44 · FY2024 · NS
Understanding molecular rules governing protein allostery by deep mutational scanning
$2,146,877Srivatsan Raman · University Of Wisconsin-Madison · DP2 · FY2018 · GM
Center for Translational Neuroscience
$2,146,088Edgar E Garcia-Rill · Univ Of Arkansas For Med Scis · P20 · FY2010 · RR
BIOLOGY OF OVARIAN CANCER
$2,145,992University Of California San Francisco · P01 · FY2002 · CA
Genomic and synthetic biology tools for expressing natural product gene clusters
$2,145,981Ronald Wayne Davis · Stanford University · U01 · FY2017 · GM
Pharmaco Response Signatures and Disease Mechanism
$2,145,458Peter Karl Sorger · Harvard Medical School · U54 · FY2015 · HL
Pharmaco Response Signatures and Disease Mechanism
$2,145,458Peter Karl Sorger · Harvard Medical School · U54 · FY2014 · HL